Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Zamboni

Showing results (81-90 of 180) with videos related to

Pageof 18
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 23, 2022
COVID-19 Vaccines and the Virus: Impact on Drug Metabolism and PharmacokineticsEliza R McColl, Maria A Croyle, William C Zamboni, et al.
The International Journal of Prosthodontics|December 15, 2006
Does the thickness of the resin cement affect the bond strength of a fiber post to the root dentin?Bianca E M Perez, Silvia H Barbosa, Renata M Melo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 15, 2019
Phase I study of intravenous oxaliplatin and intraperitoneal docetaxel in recurrent ovarian cancerSarah E Taylor, Jennifer S Petschauer, Heidi Donovan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
A pilot study of protracted topotecan dosing using a pharmacokinetically guided dosing approach in children with solid tumorsVictor M Santana, William C Zamboni, Mark N Kirstein, et al.
Cancer Chemotherapy and Pharmacology|October 6, 2005
Clinical and pharmacokinetic study evaluating the effect of food on the disposition of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite in patients with solid tumorsWilliam C Zamboni, Sanjay Goel, Tahir Iqbal, et al.
Anti-Cancer Drugs|April 1, 1997
Efficacy of oral irinotecan against neuroblastoma xenograftsJ Thompson, W C Zamboni, P J Cheshire, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 7, 2012
Best practices in cancer nanotechnology: perspective from NCI nanotechnology allianceWilliam C Zamboni, Vladimir Torchilin, Anil K Patri, et al.
Genes, Brain, and Behavior|March 3, 2015
Initial locomotor sensitivity to cocaine varies widely among inbred mouse strainsT Wiltshire, R B Ervin, H Duan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Altered irinotecan and SN-38 disposition after intravenous and oral administration of irinotecan in mice bearing human neuroblastoma xenograftsW C Zamboni, P J Houghton, J Thompson, et al.
Neoplasia (New York, N.Y.)|September 21, 2006
Endothelin receptor A blockade enhances taxane effects in prostate cancerArdavan Akhavan, Kevin H McHugh, Georgi Guruli, et al.
Pageof 18

Showing results (81-90 of 180) with videos related to

Sort By:
Pageof 18
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 23, 2022
COVID-19 Vaccines and the Virus: Impact on Drug Metabolism and PharmacokineticsEliza R McColl, Maria A Croyle, William C Zamboni, et al.
The International Journal of Prosthodontics|December 15, 2006
Does the thickness of the resin cement affect the bond strength of a fiber post to the root dentin?Bianca E M Perez, Silvia H Barbosa, Renata M Melo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 15, 2019
Phase I study of intravenous oxaliplatin and intraperitoneal docetaxel in recurrent ovarian cancerSarah E Taylor, Jennifer S Petschauer, Heidi Donovan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
A pilot study of protracted topotecan dosing using a pharmacokinetically guided dosing approach in children with solid tumorsVictor M Santana, William C Zamboni, Mark N Kirstein, et al.
Cancer Chemotherapy and Pharmacology|October 6, 2005
Clinical and pharmacokinetic study evaluating the effect of food on the disposition of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite in patients with solid tumorsWilliam C Zamboni, Sanjay Goel, Tahir Iqbal, et al.
Anti-Cancer Drugs|April 1, 1997
Efficacy of oral irinotecan against neuroblastoma xenograftsJ Thompson, W C Zamboni, P J Cheshire, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 7, 2012
Best practices in cancer nanotechnology: perspective from NCI nanotechnology allianceWilliam C Zamboni, Vladimir Torchilin, Anil K Patri, et al.
Genes, Brain, and Behavior|March 3, 2015
Initial locomotor sensitivity to cocaine varies widely among inbred mouse strainsT Wiltshire, R B Ervin, H Duan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Altered irinotecan and SN-38 disposition after intravenous and oral administration of irinotecan in mice bearing human neuroblastoma xenograftsW C Zamboni, P J Houghton, J Thompson, et al.
Neoplasia (New York, N.Y.)|September 21, 2006
Endothelin receptor A blockade enhances taxane effects in prostate cancerArdavan Akhavan, Kevin H McHugh, Georgi Guruli, et al.
Pageof 18